Korczyńska Małgorzata, Kulikowska Joanna, Celiński Rafał, Nowicka Joanna, Rojek Sebastian, Uttecht-Pudełko Anna
Z Katedry i Zakładu Medycyny Sadowej i Toksykologii Sadowo-Lekarskiej, Slaskiego Uniwersytetu Medycznego w Katowicach.
Arch Med Sadowej Kryminol. 2011 Jan-Mar;61(1):35-42.
In the paper, the authors present the results of toxicological examinations of blood samples taken from drivers during road check procedures or from perpetrators of traffic road accidents, which--taking into consideration the kind of the determined agents and their concentrations--were compared with the results of medical examinations from blood sampling protocols studied in the Department of Forensic Medicine and Toxicology, Silesian University of Medicine. All the blood samples were first analyzed using an immunoenzymatic assay (ELISA). Then, the LC-MS method was used. The positive results of screening for the presence of cannabinols were verified by GC-MS. Out of 329 blood samples, 145 were positive. The presence of cannabinols, amphetamine or MDMA was the most predominant finding. Diazepam was determined in 4 cases and opiates in 1 case. Only in 31% cases did positive results of toxicological examinations correspond to deviations found during the medical examinations constituting the basis for the final diagnosis of state "under the influence". In practice, appraisal of drug influence during medical examination seems to be limited and dependent on variable reactions of the examined individuals to a psychoactive agent, time lapse between the traffic road event and the examination or concomitant symptoms associated with ethylene alcohol activity. The final diagnosis of state "under the influence of drugs" or "under the influence of psychotropic agents" given by the physician does not result from the effect of these substances observed during the medical examination, but is very often formulated based on the medical history or police findings. The analysis of the above mentioned cases where Delta9THC or/and amphetamine was detected showed no correlation between the concentration of the psychoactive agent determined in blood and symptoms triggered by its action as described by the physician.
在该论文中,作者展示了在道路检查程序中从驾驶员或交通事故肇事者采集的血样的毒理学检查结果,这些结果——考虑到所检测物质的种类及其浓度——与西里西亚医科大学法医学与毒理学系研究的血样采集方案中的医学检查结果进行了比较。所有血样首先使用免疫酶测定法(ELISA)进行分析。然后,采用液相色谱 - 质谱法(LC - MS)。大麻酚存在的筛查阳性结果通过气相色谱 - 质谱法(GC - MS)进行验证。在329份血样中,145份呈阳性。大麻酚、苯丙胺或摇头丸的存在是最主要的检测结果。在4例中检测到地西泮,1例中检测到阿片类药物。只有31%的毒理学检查阳性结果与构成“受影响”状态最终诊断依据的医学检查中发现的偏差相符。在实践中,医学检查期间对药物影响的评估似乎有限,并且取决于被检查个体对精神活性物质的不同反应、交通事故与检查之间的时间间隔或与乙醇活性相关的伴随症状。医生给出的“受药物影响”或“受精神药物影响”状态的最终诊断并非源于医学检查期间观察到的这些物质的影响,而是常常基于病史或警方调查结果来做出。对上述检测到Δ9四氢大麻酚或/和苯丙胺的案例分析表明,血液中测定的精神活性物质浓度与其作用引发的症状之间不存在相关性,医生对此也有描述。